Italian national survey of blood donors: external quality assessment (EQA) of syphilis testing.
The detection of syphilis among blood donors may reveal high-risk sexual behavior, which can go unreported at the time of donor selection and compromise the safety of the donated blood. In Italy, blood is collected, tested, and distributed by transfusion services (TSs), which also perform outpatient transfusions. Although the TSs must screen for syphilis by law, there are no indications of the specific type of method to be used, generating discrepancies in the results obtained by the different TSs. To determine the proficiency of the TSs in screening for syphilis, we performed an external quality assessment (EQA). The EQA was based on two shipments of serum panels; 133 and 118 of the 326 existing TSs participated in the first and second shipments, respectively. Each panel consisted of both positive and negative serum samples. The results confirmed that the use of a single nontreponemal test (the Venereal Disease Research Laboratory [VDRL] and the rapid plasma reagin [RPR] tests) is the least sensitive means of identifying samples that are positive for syphilis antibodies. We also found that the interpretation of the results of manual techniques, such as the RPR test, the VDRL test, the Treponema pallidum hemagglutination (TPHA) assay, and the T. pallidum particle agglutination (TPPA) assay, can vary greatly among different TSs and operators. Total Ig enzyme immunoassays (EIAs) are the most sensitive. However, the determination of syphilis on the basis of the results of a single test is not sufficient for an accurate screening; and all blood units should thus be assessed by two distinct treponemal tests, that is, a total Ig EIA and the TPHA or the TPPA assay.
Vulcano
Francesca
F
Section of Transfusion Methodologies, Department of Hematology, Oncology, and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Milazzo
Luisa
L
Volpi
Sabrina
S
Battista
Mara Maria
MM
Barca
Alessandra
A
Hassan
Hamisa Jane
HJ
Pimpinelli
Fulvia
F
Giampaolo
Adele
A
D000907:Antibodies, Bacterial / Q000097:blood; D001431:Bacteriological Techniques / Q000592:standards*; D001782:Blood Donors; D002308:Cardiolipins / Q000032:analysis; D002784:Cholesterol / Q000032:analysis; D006302:Health Services Research; D006386:Hemagglutination Tests; D006801:Humans; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G / Q000097:blood; D007558:Italy; D010713:Phosphatidylcholines / Q000032:analysis; D011935:Reagins / Q000032:analysis; D012680:Sensitivity and Specificity; D013587:Syphilis / Q000175:diagnosis* / Q000517:prevention & control / Q000635:transmission*; D014210:Treponema pallidum / Q000302:isolation & purification*
D000907:Antibodies, Bacterial; D002308:Cardiolipins; D007074:Immunoglobulin G; D010713:Phosphatidylcholines; D011935:Reagins; C054448:VDRL antigen; D002784:Cholesterol